Finance

Lists
THAT:LON
Thalia Therapeutics PLC
GBX 0.62
0.00%
(0.00) 1D
Oct 19, 4:35:14 PM GMT+1  ·   GBX
All symbols
SymbolPriceChange% Change
Generating top insights for THAT...
Mkt. cap
11.08M
Avg. vol.
1.02M
Volume
0.00
Shares outstanding
1.78B
No. of employees
3
Mkt. cap
11.08M
Avg. vol.
1.02M
Volume
0.00
Shares outstanding
1.78B
No. of employees
3
News stories
From web sources and news partners
About Thalia Therapeutics PLC
CEO-
Employees3
Founded1979
Headquarters-
SectorPharmaceutical industry
Websitethaliatx.com
Previous reportsAll values in GBP
Loading Previous Earnings...
Revenue
Net income
All values in GBP
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.79K
1.79K
1.82K
1.82K
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
73.40K
73.40K
14.08K
14.08K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
306.45K
306.45K
366.33K
366.33K
Operating expense
349.29K
349.29K
380.42K
380.42K
Total operating expenses
349.29K
349.29K
380.42K
380.42K
Operating income
-347.50K
-347.50K
-378.60K
-378.60K
Other non operating income
40.00
40.00
-
-
EBT including unusual items
-347.46K
-347.46K
-378.60K
-378.60K
EBT excluding unusual items
-347.46K
-347.46K
-378.60K
-378.60K
Income tax expense
5.81K
5.81K
-
-
Effective tax rate
-1.67%
-1.67%
-
-
Other operating expenses
-30.56K
-30.56K
-
-
Net income
-353.23K
-353.23K
-377.47K
-377.47K
Net profit margin
-19,766.59%
-19,766.59%
-20,728.56%
-20,728.56%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps